Search Results 1251-1260 of 6814 for 谷歌搜索留痕工具咨询邮箱:lgooxc@hotmail.com
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to see if there is a subjective improvement in operative time, incision length, volume of tissue removed and ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
The purpose of this study is to whether the QuickSIN with 0.3 sec reverberation time is a better method than the standard (no reverberation) QuickSIN of ...
The primary purpose of this study is to evaluate whether early treatment with therapeutic hypothermia (TH), along with neuromuscular blockade (NMB) to prevent ...
The purpose of this study is to document characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Vercise™ System for ...
The atezolizumab plus obinutuzumab) (Arm E) will enroll participants with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.
The purpose of this study is to collect adiopose tissue to derive mesenchymal stem cells. Participation eligibility. Participant eligibility includes age, ...
Contact information for Dr. Badley's Human Immunodeficiency Virus Laboratory at Mayo Clinic's campus in Minnesota.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.